• Frequently Asked Questions About a GLP-1 RA Treatment Option for T2D

  • Oct 27 2023
  • Length: 42 mins
  • Podcast

Frequently Asked Questions About a GLP-1 RA Treatment Option for T2D

Listen for free

View show details

  • Summary

  • What do you need to know about a once daily GLP-1 RA therapy for adults with T2D? Join experts in T2D Aaron King, MD, Helen Baron, MD, and Stephen Brunton, MD, FAAP, FRACGP, CDCES, as they discuss frequently asked questions regarding the use of a once daily treatment for adults with T2D with the goal of helping to provide answers. Key topics include dosing and administration, handling and storage, as well as efficacy and safety.

    This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

    Faculty Presenters:

    Aaron King, MD
    Physician
    Baptist Health System Physicians 
    San Antonio, TX

    Helen L. Baron, MD
    Medical Director, Diabetes Services
    Eisenhower Diabetes and Endocrinology
    Montrose, CA

    Stephen Brunton, MD, FAAFP, CDCES
    Executive Director
    Primary Care Metabolic Group
    Winnsboro, SC
    Show More Show Less
Show More Show Less

What listeners say about Frequently Asked Questions About a GLP-1 RA Treatment Option for T2D

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.